Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Ibrexafungerp for the Treatment of Complicated Vulvovaginal Candidiasis

ClinicalTrials.gov ID: NCT05399641

Public ClinicalTrials.gov record NCT05399641. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 4:50 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Oral Ibrexafungerp for the Treatment of Complicated Vulvovaginal Candidiasis (VVC) in Subjects Who Have Failed Fluconazole Therapy

Study identification

NCT ID
NCT05399641
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Scynexis, Inc.
Industry
Enrollment
150 participants

Conditions and interventions

Interventions

  • Ibrexafungerp Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2022
Primary completion
May 15, 2023
Completion
Aug 1, 2023
Last update posted
Jul 9, 2024

2022 – 2023

United States locations

U.S. sites
25
U.S. states
19
U.S. cities
23
Facility City State ZIP Site status
Precision Trials, AZ Phoenix Arizona 85032
Women's Healthcare Research San Diego California 92111
Wake Research (MCCR) San Diego California 92120
New Age Medical Research Miami Florida 33186
Wake (Mount Vernon Clinical Research) Atlanta Georgia 30328
Clinical Research Prime Idaho Falls Idaho 83404
Leavitt Women's Healthcare Idaho Falls Idaho 83404
Women Under Study New Orleans Louisiana 70125
Massachusetts's General Boston Massachusetts 02114
Wayne State University Detroit Michigan 48201
Consultants in Women's Healthcare St Louis Missouri 63131
Wake Research (CRCN) Las Vegas Nevada 89123
Capital Health Lawrence OBGYN Lawrenceville New Jersey 08648
Center for Colposcopy Lake Success New York 11042
Wake Research (Carolina Institute for Clinical Research) Fayetteville North Carolina 28303
UWCR - Raleigh Raleigh North Carolina 27607
Lyndhurst Clinical Research Winston-Salem North Carolina 27103
Cleveland Clinic Cleveland Ohio 44195
Oregon Health and Science University Portland Oregon 97239
Jefferson University Philadelphia Pennsylvania 19107
Medical Research Center Memphis Tennessee 38120
Discovery Clinical Trials Dallas Texas 75230
TMC Life Research, Inc Houston Texas 77054
Discovery Clinical Trials McAllen Texas 78503
Seattle Clinical Research Center Seattle Washington 98105

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05399641, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 9, 2024 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05399641 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →